Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies

Brain

Volumn 126, Issue 2, 2003, Pages 361-375

  Kwa, Marcel S G ^a   Van Schaik, Ivo N ^a   De Jonge, Rosalein R ^a   Brand, Anneke ^b   Kalaydjieva, Luba ^d   Van Belzen, Nico ^c   Vermeulen, Marinus ^a   Baas, Frank ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DMV International   (Netherlands)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Autoantibody; Guillain Barr ; Nerve; Neuropathy; Schwann

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MYELIN; MYELIN PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHILD; CHRONIC INFLAMMATORY DEMYELINATING NEUROPATHY; DEMYELINATION; EPITOPE MAPPING; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; INFLAMMATORY NEUROPATHY; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; NERVE GROWTH; NEUROPATHY; PERIPHERAL NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; SCHWANN CELL; STAINING;

EID: 0037312632     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg030     Document Type: Article

References (53)

1. Aarts LH, Verkade P, van Dalen JJ, van Rozen AJ, Gispen WH, Schrama L, et al. B-50/GAP-43 potentiates cytoskeletal reorganization in raft domains. Mol Cell Neurosci 1999; 14: 85-97.
2. Ad hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). [Review]. Neurology 1991; 41: 617-8.
3. Araki T, Milbrandt J. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 1996; 17: 353-61.
4. Araki T, Milbrandt J. Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. J Neurosci 2000; 20: 187-95.
5. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. [Review]. Trends Neurosci 2000; 23: 317-27.
6. Archelos JJ, Previtali SC, Hartung HP. The role of integrins in immune-mediated diseases of the nervous system. [Review]. Trends Neurosci 1999; 22: 30-8.
7. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. [Review]. Ann Neurol 1990; 27 Suppl: S21-4.
8. Brand A, Vuist WM, van Schaik IN, Vermeulen M. In vitro investigation of immunoglobulin treatment mechanisms in autoimmune diseases. [Review]. Clin Exp Rheumatol 1996; 14 Suppl 15: S27-30.
9. Brockes JP, Fields KL, Raff MC. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 1979; 165: 105-18.
10. Curtis R, Stewart HJ, Hall SM, Wilkin GP, Mirsky R, Jessen KR. GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J Cell Biol 1992; 116: 1455-64.
11. DeJonge RR, van Schaik IN, Vermeulen M, Kwa MS, Baas F. cAMP is involved in the differentiation of human teratocarcinoma cells. Neurosci Lett 2001; 311: 61-5.
12. Furley AJ, Morton SB, Manalo D, Karagogeos D, Dodd J, Jessel TM. The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity. Cell 1990; 61: 157-70.
13. Gabriel CM, Hughes RA, Moore SE, Smith KJ, Walsh FS. Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 1998; 121: 1895-902.
14. Gabriel CM, Gregson NA, Hughes RA. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 2000; 104: 139-46.
15. Hafer-Macko CE, Sheikh KA, Li C, Ho TW, Cornblath DR, McKahnn GM, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996; 39: 625-35.
16. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Muller HW. Improved culture methods to expand Schwann cells with altered growth behavior from CMT1A patients. Glia 1998; 23: 89-98.
17. Haney CA, Sahenk Z, Li C, Lemmon VP, Roder J, Trapp BD. Heterophilic binding of L1 on unmyelinated sensory axons mediates Schwann cell adhesion and is required for axonal survival. J Cell Biol 1999; 146: 1173-84.
18. Ho TW, McKhann GM, Griffin JW. Human autoimmune neuropathies. [Review]. Annu Rev Neurosci 1998; 21: 187-226.
19. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999; 45: 168-73.
20. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, et al. Expression and structure of the human NGF receptor. Cell 1986; 47: 545-554.
21. Kadlubowski M, Hughes RA. Identification of the neuritogen for experimental allergic neuritis. Nature 1979; 277: 140-1.
22. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge RR, et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 2000; 67: 47-58.
23. Koski CL. Mechanisms of Schwann cell damage in inflammatory neuropathy. [Review]. J Infect Dis 1997; 172 Suppl 2: S169-72.
24. Kwa MS, van Schaik IN, Brand A, Baas F, Vermeulen M. Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies. J Neuroimmunol 2001; 116: 220-5.
25. Lemke G, Chao M. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development 1988; 102: 499-504.
26. 0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 1987; 79: 275-85.
27. Mirsky R, Jessen KR. Schwann cell development, differentiation and myelination. [Review]. Curr Opin Neurobiol 1996; 6: 89-96.
28. Morrison SJ, White PM, Zock C, Anderson DJ. Prospective identification, isolation by flow cytometry, and in vivo selfrenewal of multipotent mammalian neural crest stem cells. Cell 1999; 96: 737-49.
29. erbB2. Proc Natl Acad Sci USA 1995; 92: 1431-35.
30. Oestreicher AB, De Graan PN, Gispen WH, Verhaagen J, Schrama LH. B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. [Review]. Prog Neurobiol 1997; 53: 627-86.
31. Plantinga LC, Verhaagen J, Edwards PM, Hol EM, Bar PR, Gispen WH. The expression of B-50/GAP-43 in Schwann cells is upregulated in degenerating peripheral nerve stumps following nerve injury. Brain Res 1993; 602: 69-76.
32. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997; 349: 225-30.
33. Pleasure SJ, Lee VM. NTera2 cells: a human cell line, which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 1993; 35: 585-602.
34. Previtali SC, Archelos JJ, Hartung HP. Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome. Ann Neurol 1998; 44: 611-21.
35. Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of GuilllainBarré syndrome. J Neurol Sci 2000; 174: 16-21.
36. Ritz MF, Lechner-Scott J, Scott RJ, Fuhr R, Malik N, Erne B, et al. Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J Neuroimmunol 2000; 104: 155-63.
37. Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon G. Purification and expansion of human Schwann cells in vitro. Nat Med 1995; 1: 80-3.
38. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291: 484-6.
39. Scherer SS. The biology and pathobiology of Schwann cells. [Review]. Curr Opin Neurol 1997; 10: 386-97.
40. Soilu-Hänninen M, Ekert P, Bucci T, Syroid D, Bartlett P, Kilpatrick TJ. Nerve growth factor signaling through p75 induces apoptosis in Schwann cells via a Bcl-2-independent pathway. J Neurosci 1999; 19: 4828-38.
41. Steck AJ, Schaeren-Wiemers N, Hartung HP. Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome. [Review]. Curr Opin Neurol 1998; 11: 311-8.
42. Stewart HJ, Curtis R, Jessen KR, Mirsky R. TGF-βs and cAMP regulate GAP-43 expression in Schwann cells and reveal the association of this protein with the trans-Golgi network. Eur J Neurosci 1995; 7: 1761-72.
43. Suter DM, Forscher P. An emerging link between cytoskeletal dynamics and cell adhesion molecules in growth cone guidance. [Review]. Curr Opin Neurobiol 1998; 8: 106-16.
44. vanBelzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997; 77: 85-92.
45. vanderPol WL, van den Berg LH, Scheepers RH, van der Bom JG, van Doorn PA, van Konigsveld R. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome. Neurology 2000; 54: 1661-5.
46. vanSchaik IN, Bossuyt PM, Brand A, Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology 1995; 45: 1570-7.
47. vanSchaik IN, Vermeulen M, Brand A. Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies? [Review]. Mult Scler 1997; 3: 98-104.
48. Vedeler CA, Raknes G, Myhr KM, Nyland H. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology 2000; 55: 705-7.
49. Walsh FS, Doherty P. Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance. [Review]. Annu Rev Cell Dev Biol 1997; 13: 425-56.
50. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genet 1998; 18: 382-4.
51. Yan WX, Taylor J, Andrias-Kauba S, Pollard JD. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 2000; 47: 765-75.
52. 0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001; 50: 286-92.
53. Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 2001; 73: 86-97.